Quality is paramount at Benchmark Research. Safety comes first and our procedures reflect that commitment. Our quality assurance program is guided by a former FDA investigator with extensive training experience and more than 30 years in the research industry at both site and industry levels.
Benchmark maintains an active Clinical Trial Quality Plan that defines proactive procedures to ensure that all trials are compliant with ICH and GCP guidelines, FDA regulations, sponsor requirements, protocol requirements and Benchmark policies. The plan includes real-time, day to day observation and documentation of site work processes to ensure procedures are followed.
Further, all staff adhere to a continual learning and improvement program to maintain our high-quality levels in everything we do.
Experienced Call Center Support
Benchmark’s centralized Call Center coordinates and implements targeted study recruitment and retention campaigns. The Call Center directs qualified patients to the appropriate research location, places reminder calls for all appointments, and reschedules visits for patients’ convenience and according to protocol specified windows.
Consequently, Benchmark sites have extraordinarily low early termination and lost-to-follow-up numbers. Our state-of-the- art study management programs monitor activity and progress at all sites.
Dedicated, Skilled Coordinators
Experienced and driven Clinical Research Coordinators are integral to the success of any trial. Benchmark’s talented specialists consistently exceed sponsor expectations. Our CRCs are highly trained on Benchmark SOPs as well as GCP and FDA guidelines. Benchmark’s internal, comprehensive CRC training program is designed to guide new coordinators to certification-level quality and provide experienced coordinators with ongoing and advanced state of the industry training. The majority of Benchmark coordinators are CCRC certified.
Our research coordinators are experienced in managing all aspects of a particular trial and are recognized as creative problem solvers due to their innovative efforts to improve targeted recruiting strategies.
Experienced, Focused Investigators
Benchmark’s team of motivated and focused investigators offers clinical trials experience in a wide range of therapeutic areas. Our knowledgeable investigators enthusiastically embrace clinical research and the opportunities that new therapies bring to both the marketplace and the patient. Dedication and experience aside, our investigators are also highly trained in GCP and FDA regulations.
Each Investigator participates in Benchmark’s ongoing internal investigator training program. Our investigators go the extra mile to ensure smooth conduct of your clinical trial. In addition to protocol-specific responsibilities and GCP/FDA requirements, you can count on our doctors to attend investigator meetings, actively recruit patients from their private practice, meet with CRAs during monitoring visits and offer qualitative feedback regarding your clinical trial. All of our investigators share the goal of providing you with accurate, high-quality data.
Innovative Advertising Team
Our advertising staff has spent years placing study advertisements with pinpoint accuracy for recruiting patients based on demographics outlined in the study protocols. Depending on the advertising budget, we can place targeted news releases, high-impact newspaper or periodical advertising, custom-designed study-specific direct mail, broadcast, and digital advertising.
With a keen understanding of our individual site markets, we continually hone patient databases to guarantee appropriate and robust recruitment. Currently, more than 100,000 active patients are categorized by age, gender, condition, and location.
Knowledgeable Supervisory Team
Our teams of supervisors start each trial by promptly reviewing each protocol to ensure Benchmark maximizes recruitment during the proposed study timeline. We identify potential roadblocks, create innovative recruitment strategies, and once we accurately assess study progress – adjust based on actual versus desired results.
Our supervisors meet weekly with site directors to evaluate enrollment and share information. Changes in enrollment activity are continually reviewed and analyzed, and if warranted, new or improved recruitment plans are formulated and rapidly implemented. Site directors hold meetings regularly with investigator staff to discuss new studies, as well as refresh and reinvigorate Benchmark personnel regarding ongoing protocols. Additionally, up-to-date pocket sized reminders of inclusion / exclusion criteria are provided to physicians and nursing staff for each individual study.
In sum, Benchmark Research is nimble, dedicated, proactive, and highly professional. Your Benchmark team gladly welcomes today’s exciting challenges and opportunities in pharmaceutical research.
VaxCorps is a network of highly experienced, geographically diverse clinical research centers specializing in the conduct of vaccine trials in healthy adult, elderly, and pediatric populations. VaxCorps clinical sites have successfully conducted over 500 phase I-IV vaccine clinical trials, with extensive experience in seasonal and pandemic influenza as well as a vast array of other infectious and biodefense vaccine indications. As industry leaders, VaxCorps is committed to the highest standard of research excellence with subject safety, data integrity, rapid study startup and enrollment, and outstanding subject retention as top priorities.
The Benchmark Research Leadership Team
Mark Lacy – Founder & Chief Executive Officer
Scott Barrett – President & Chief Operating Officer
Deborah Copeland – Chief Operations Officer
Cynthia Dukes – Chief Business Officer
Melissa Reynolds – Executive Vice President, Clinical Operations
Jennifer Bacchi – Vice President, Human Capital Management
Kim Brittain – Vice President, Strategic Development & Analytics
Van Johnson – Executive Director, Business Development
If you would like to discuss how Benchmark can help you with your next clinical project, complete the form below and a member of our leadership team will contact you.